Update on the Latest Developments in Viral and Non-Viral Vector Manufacturing

Guest Editor: Dr Jan Thirkettle, Chief Development Officer, Freeline Therapeutics


Building upon the February 2018 Spotlight on Viral and Non-Viral Vector Manufacturing, this series of interviews, articles and webinars will provide an update on the latest developments in optimizing vector and plasmid manufacturing.

Hear from key opinion leaders on the cutting-edge scientific approaches being developed in efforts to refine vector performance, as well as advances in technology platforms to streamline and improve efficiencies in the manufacture of these crucial approaches.

Coming in November 2018